Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Taming platelets with cyclic nucleotides.

U R Schwarz1, U Walter, M Eigenthaler

  • 1Institut für Klinische Biochemie und Pathobiochemie, Medizinische Universitätsklinik, Josef-Schneider Str. 2, 97080, Würzburg, Germany.

Biochemical Pharmacology
|November 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Live-cell imaging reveals decreased cAMP in a PFE-associated c.1050-3C>G PTH1R cell model.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

The diagnostic value of transcranial sonography in Swedish parkinsonism patients: A retrospective cohort study with long-term follow-up.

Clinical parkinsonism & related disorders·2026
Same author

Early Effects of Communities That Care on the Adoption and Implementation Fidelity of Evidence-Based Prevention Programs in Communities: Results from a Quasi-experimental Study.

Prevention science : the official journal of the Society for Prevention Research·2025
Same author

Effects of a Brief Web-Based "Social Norms"-Intervention on Alcohol, Tobacco and Cannabis Use Among German University Students: Results of a Cluster-Controlled Trial Conducted at Eight Universities.

Frontiers in public health·2021
Same author

[Obituary for Prof. Dr. Reiner Benecke (1949-2017)].

Der Nervenarzt·2017
Same author

[Digital electroencephalography in brain death diagnostics : Technical requirements and results of a survey on the compatibility with medical guidelines of digital EEG systems from providers in Germany].

Der Nervenarzt·2017
Same journal

Mapk-driven remodeling of mitochondrial dynamics in melanoma: implications for metabolic plasticity and response to targeted therapy.

Biochemical pharmacology·2026
Same journal

Unraveling the multifaceted roles of the aryl hydrocarbon receptor in the central nervous system: neurogenesis, neural function, and disease.

Biochemical pharmacology·2026
Same journal

4-DMB, a diclofenac derivative, alleviates DSS-induced ulcerative colitis in mice by binding TNFR1 to inhibit inflammation.

Biochemical pharmacology·2026
Same journal

Calceolarioside B alleviates airway barrier dysfunction and inflammation via targeting P2Y<sub>6</sub>R in OVA-triggered asthma.

Biochemical pharmacology·2026
Same journal

The dual-faced pyruvate kinase M2 in tumors: From cytoplasmic metabolic gatekeeper to nuclear transcriptional coactivator.

Biochemical pharmacology·2026
Same journal

A [<sup>68</sup>Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens.

Biochemical pharmacology·2026
See all related articles

Platelet activation contributes to cardiovascular diseases. Cyclic nucleotides like cAMP and cGMP inhibit platelet function by targeting key signaling pathways, offering potential therapeutic strategies for thrombotic disorders.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Pharmacology

Background:

  • Pathologic platelet activation exacerbates cardiovascular diseases.
  • Platelet function regulation is crucial for cardiovascular health and therapy.
  • Physiological antagonists and vasodilators inhibit platelet function via cyclic nucleotides.

Purpose of the Study:

  • To explore the role of cyclic nucleotides in regulating platelet function.
  • To understand the molecular mechanisms by which cyclic nucleotides inhibit platelet activation.
  • To identify therapeutic targets for cardiovascular and thrombotic disorders.

Main Methods:

  • Investigated the effects of cyclic AMP (cAMP) and cyclic GMP (cGcGMP) on platelet signaling pathways.
  • Analyzed the impact of cyclic nucleotides on protein kinase activation and substrate phosphorylation.

Related Experiment Videos

  • Examined the influence of cyclic nucleotides on cytoskeletal organization and calcium signaling in platelets.

    • Main Results:

    • Elevated cAMP and cGMP levels interfere with major platelet activation pathways.
    • Cyclic nucleotides inhibit signaling cascades including phospholipase C, protein kinase C, and MAPK pathways.
    • These effects lead to reduced calcium mobilization and cytoskeletal rearrangements essential for platelet function.

    Conclusions:

    • Cyclic nucleotides are potent inhibitors of platelet activation through multiple signaling mechanisms.
    • Targeting cyclic nucleotide pathways offers a promising strategy for treating thrombotic and cardiovascular diseases.
    • Understanding these pathways can lead to novel therapeutic interventions for cardiovascular disorders.